Purine nucleotides reduce superoxide production by nitric oxide synthase in a murine sepsis model.
Sepsis involves a systemic inflammatory response of multiple endogenous mediators, resulting in many of the injurious and sometimes fatal physiological symptoms of the disease. This systemic activation leads to a compromised vascular response and endothelial dysfunction. Purine nucleotides interact with purinoceptors and initiate a variety of physiological processes that play an important role in maintaining cardiovascular function. The purpose of the present study was to investigate the effects of ATP on vascular function in a lipopolysaccharide (LPS) model of sepsis. LPS induced a significant increase in aortic superoxide production 16 h after injection. Addition of ATP to the organ bath incubation solution reduced superoxide production by the aortas of endotoxemic animals. Reactive Blue, an antagonist of the P2Y receptor, blocked the effect of ATP on superoxide production, and the nonselective P2Y agonist MeSATP inhibited superoxide production. Nitric oxide synthase (NOS) inhibition by L-NAME blocked vascular relaxation and reduced superoxide production in LPS-treated animals. In the presence of L-NAME there was no ATP effect on superoxide production. A vascular reactivity study showed that ATP increased maximal relaxation in LPS-treated animals compared to controls. The presence of ATP induced increases in Akt and endothelial NOS phosphorylated proteins in the aorta of septic animals. ATP reduces superoxide release resulting in an improved vasorelaxant response. Sepsis may uncouple NOS to produce superoxide. We showed that ATP through Akt pathway phosphorylated endothelial NOS and "re-couples" NOS function.
Emergências Clínicas, Departamento de Clínica Médica (LIM51), Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
H V
HV
Barbeiro
D F
DF
Barbeiro
V
V
Debbas
H P
HP
Souza
F R
FR
Laurindo
I T
IT
Velasco
F G
FG
Soriano
D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D001013:Aorta, Thoracic / Q000201:enzymology* / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000201:enzymology* / Q000503:physiopathology; D008070:Lipopolysaccharides; D008297:Male; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D010766:Phosphorylation; D011685:Purine Nucleotides / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D018805:Sepsis / Q000201:enzymology* / Q000503:physiopathology; D013481:Superoxides / Q000378:metabolism*
D008070:Lipopolysaccharides; D011685:Purine Nucleotides; D013481:Superoxides; D000255:Adenosine Triphosphate; D019001:Nitric Oxide Synthase